Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Supplementary material for article published in Clinical Experimental Allergy (Baumann et al): Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria
创建时间：
2023-06-22
